Advertisement

Psoriasis in Skin of Color

  • Leah A. Cardwell
  • Chelsea Kesty
  • Steven R. Feldman
  • Amy J. McMichael
Chapter

Abstract

Psoriasis is a chronic inflammatory disease that affects approximately 3.2% of the adult population of the USA. Amongst this population, Caucasians have the highest prevalence rate at 3.6%, while in non-Caucasians or individuals with skin of color the prevalence is lower, 1.9%, 1.6%, and 1.4% in African Americans, Hispanics, and other non-Caucasians, respectively [1]. Based on these statistics, one might gather that psoriasis is less likely in skin of color [2]. One of the earliest review articles detailing psoriasis prevalence by ethnic origin highlights several groups including the specific categories: Caucasian, African American, black-skinned South African, Fiji Islands, American Indian, Latin American Indian, Japanese, and Indonesians [3]. The 1965 text perpetuates the idea that psoriasis is relatively common in Caucasians and much less frequent in skin of color while acknowledging that psoriasis may not be as rare in those of African descent as previously believed. It was proposed that in evaluating the incidence of psoriasis among different ethnic groups, the potential influence of variables such as genetics, climate, diet, degree of skin pigmentation, exercise, stress level, economic factors, social factors, and hygiene factors must be considered [3]. This study was subject to selection bias as the text concluded that psoriasis was uncommon in black-skinned individuals during a time period when black-skinned individuals with psoriasis were much less likely to visit the dermatologist than white Caucasians.

References

  1. 1.
    Rachakonda TD, Schupp CW, Armstrong AW. Psoriasis prevalence among adults in the United States. J Am Acad Dermatol. 2014;70:512–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Gelfand JM, Stern RS, Nijsten T, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52:23–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Farber EM, Grauer FZF. Racial incidence of psoriasis. Cesk Dermatol. 1965;40:289–97.PubMedGoogle Scholar
  4. 4.
    Porto Ferreira C, Martins CJ, Issa PR, et al. Psoriasis affects individuals of African descent and white Brazilians similarly. Actas Dermosifiliogr. 2010;101:230–4.CrossRefPubMedGoogle Scholar
  5. 5.
    Leder RO, Farber EM. The variable incidence of psoriasis in sub-Saharan Africa. Int J Dermatol. 1997;36:911–9.CrossRefPubMedGoogle Scholar
  6. 6.
    Parisi R, Symmons DPM, Griffiths CEM, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2012;133:377–85.CrossRefPubMedGoogle Scholar
  7. 7.
    Balato N, Di Costanzo L, Patruno C, et al. Effect of weather and environmental factors on the clinical course of psoriasis. Occup Environ Med. 2013;70:600.CrossRefPubMedGoogle Scholar
  8. 8.
    Farber EM, Nall ML. The natural history of psoriasis in 5,600 patients. Dermatology. 1974;148:1–18.CrossRefGoogle Scholar
  9. 9.
    Andersen LK, Davis MDP. The effects of the El Nino southern oscillation on skin and skin-related diseases: a message from the International Society of Dermatology Climate Change Task Force. Int J Dermatol. 2015;54:1343–51.CrossRefPubMedGoogle Scholar
  10. 10.
    Barlow RJ, Schulz EJ. Chronic subcorneal pustulosis with vasculitis: a variant of generalized pustular psoriasis in black South Africans. Br J Dermatol. 1991;124:470–4.CrossRefPubMedGoogle Scholar
  11. 11.
    Curtis AR, Yosipovitch G. Erythrodermic verrucous psoriasis. J Dermatolog Treat. 2012;23:215–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Delaney TA, Smith NP. Lichen planus mimicking and coexisting with psoriasis in a black patient. Australas J Dermatol. 1993;34:59–62.CrossRefPubMedGoogle Scholar
  13. 13.
    McMichael AJ, Vachiramon V, Guzmán-Sánchez DA, Camacho F. Psoriasis in African-Americans: a caregivers’ survey. J Drugs Dermatol. 2012;11:478–82.PubMedGoogle Scholar
  14. 14.
    Petit A. Skin semiology and grading scales. In: Dadzie OE, Petit A, Alexis A, editors. Ethnic dermatology principles and practice. Chichester: Wiley-Blackwell; 2013. p. 5–17.CrossRefGoogle Scholar
  15. 15.
    Bowcock AM, Krueger JG. Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol. 2005;5:699–711.CrossRefPubMedGoogle Scholar
  16. 16.
    Yao Y, Richman L, Morehouse C, et al. Type I interferon: potential therapeutic target for psoriasis? PLoS One. 2008;3:e2737.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Haider AS, Lowes M, Suàrez-Fariñas M, et al. Cellular genomic maps help dissect pathology in human skin disease. J Invest Dermatol. 2008;128:606–15.CrossRefPubMedGoogle Scholar
  18. 18.
    Funk J, Langeland T, Schrumpf E, et al. Psoriasis induced by interferon-alpha. Br J Dermatol. 1991;125:463–5.CrossRefPubMedGoogle Scholar
  19. 19.
    Büchau AS, Gallo RL. Innate immunity and antimicrobial defense systems in psoriasis. Clin Dermatol. 2007;25:616–24.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361:496–509.CrossRefPubMedGoogle Scholar
  21. 21.
    Nickoloff BJ, Xin H, Nestle FO, et al. The cytokine and chemokine network in psoriasis. Clin Dermatol. 2007;25:568–73.CrossRefPubMedGoogle Scholar
  22. 22.
    Indhumathi S, Rajappa M, Chandrashekar L, et al. TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils. Br J Biomed Sci. 2015;72:168–73.CrossRefPubMedGoogle Scholar
  23. 23.
    Riveira-Munoz E, He S-M, Escaramís G, et al. Meta-analysis confirms the LCE3C_LCE3B deletion as a risk factor for psoriasis in several ethnic groups and finds interaction with HLA-Cw6. J Invest Dermatol. 2011;131:1105–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Gandhi G, Buttar BS, Albert L, et al. Psoriasis-associated genetic polymorphism in North Indian population in the CCHCR1 gene and in a genomic segment flanking the HLA-C region. Dis Markers. 2011;31:361–70.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Mrowietz U, Jessat H, Schwarz A, et al. Anthralin (dithranol) in vitro inhibits human monocytes to secrete IL-6, IL-8 and TNF-alpha, but not IL-1. Br J Dermatol. 1997;136:542–7.CrossRefPubMedGoogle Scholar
  26. 26.
    Lowenthal KE, Horn PJ, Kalb RE. Concurrent use of methotrexate and acitretin revisited. J Dermatolog Treat. 2008;19:22–6.CrossRefPubMedGoogle Scholar
  27. 27.
    van de Kerkhof PC, Cambazard F, Hutchinson PE, et al. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. Br J Dermatol. 1998;138:84–9.CrossRefPubMedGoogle Scholar
  28. 28.
    Fisher EJ, Adams BB. African American and Caucasian patients’ vehicle preference for the scalp. J Am Acad Dermatol. 2008;58(Suppl 1):1–6.Google Scholar
  29. 29.
    Farhangian ME, Anderson KL, Feldman S. Practical psoriasis management. Create Space Independent Publishing Platform; 2015.Google Scholar
  30. 30.
    Archier E, Devaux S, Castela E, et al. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. J Eur Acad Dermatol Venereol. 2012;26(Suppl 3):22–31.CrossRefPubMedGoogle Scholar
  31. 31.
    Syed ZU, Hamzavi IH. Role of phototherapy in patients with skin of color. Semin Cutan Med Surg. 2011;30:184–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Youssef RM, Mahgoub D, Mashaly HM, et al. Different narrowband UVB dosage regimens in dark skinned psoriatics: a preliminary study. Photodermatol Photoimmunol Photomed. 2008;24:256–9.CrossRefPubMedGoogle Scholar
  33. 33.
    Yeung H, Wan J, Van Voorhees AS, et al. Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol. 2013;68:64–72.CrossRefPubMedGoogle Scholar
  34. 34.
    Rendon MI, Rodriguez DA, Kawata AK, et al. Acne treatment patterns, expectations, and satisfaction among adult females of different races/ethnicities. Clin Cosmet Investig Dermatol. 2015;8:231–8.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Leah A. Cardwell
    • 1
  • Chelsea Kesty
    • 1
  • Steven R. Feldman
    • 1
  • Amy J. McMichael
    • 1
  1. 1.Department of DermatologyWake Forest University School of MedicineWinston-SalemUSA

Personalised recommendations